PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA–targeted PET Imaging Studies
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The use of [18F]- and [68Ga]-labeled inhibitors of prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of prostate cancer is now widespread. We have proposed a reporting and data system called PSMA-RADS version 1.0, which is a framework for classifying PSMA-targeted PET scans and individual findings into categories that reflect the likelihood of the presence of prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rowe, S. P., Pienta, K. J., Pomper, M. G., & Gorin, M. A. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.195255 · Cited by 170 · cited 2×
“Definitively benign/likely benign PSMA-RADS-1 PSMA-RADS-1A: Lesions without radiotracer uptake that are definitively benign PSMA-RADS-1B: Lesions with radiotracer uptake that are definitively benign PSMA-RADS-2 Low level radiotracer uptake in bone or soft tissue sites that would be atypical for metastatic PCa Equivoca…”
BackgroundSelf-citation
Cited by
Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer
Farolfi, A., Calderoni, L., Mattana, F., Mei, R., Telo, S., Fanti, S., & Castellucci, P. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.257238 · Cited by 218
“PSMA RADS PSMA RADS is a classification of PSMA PET findings into categories that reflect the likelihood of the presence of PCa (66).”
BackgroundInfluentialWerner, R. A., Bundschuh, R. A., Bundschuh, L., Javadi, M. S., Leal, J. P., Higuchi, T., Pienta, K. J., Buck, A. K., Pomper, M. G., Gorin, M. A., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.217588 · Cited by 55
Self-citationDerwael, C., Lavergne, O., Lovinfosse, P., Nechifor, V., Salvé, M., Waltregny, D., Hustinx, R., & Withofs, N. (2020) · EJNMMI Research · doi:10.1186/s13550-020-0596-4 · Cited by 23
Khatri, W., Chung, H. W., Werner, R. A., Leal, J. P., Pienta, K. J., Lodge, M. A., Gorin, M. A., Pomper, M. G., & Rowe, S. P. (2021) · Diagnostics · doi:10.3390/diagnostics11040665 · Cited by 10
“0 scoring system, the central reviewers considered PSMA-RADS-3A lesions to be lymph node or soft tissue findings that had subtle radiotracer uptake (approximately blood pool or slightly higher) and that were in a typical pattern of distribution for PCa, such as the pelvis and retroperitoneum [7,8].”
BackgroundSelf-citation
Metadata
- Authors
- Rowe, S. P., Pienta, K. J., Pomper, M. G., & Gorin, M. A.
- Venue
- European Urology
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 73
- Issue
- 4
- Pages
- 485-487
- ISSN
- 0302-2838 (ISSN-L)
- OpenAlex
- W2767225568
- Cited by
- 150
- References
- 1
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA–targeted PET Imaging Studies. https://app.cochat.ai/papers/10.1016/j.eururo.2017.10.027
- The paper
- Rowe, S. P., Pienta, K. J., Pomper, M. G., & Gorin, M. A. (2018). PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA–targeted PET Imaging Studies. European Urology. https://doi.org/10.1016/j.eururo.2017.10.027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.